Overview

Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome

Status:
Completed
Trial end date:
2019-05-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of ranolazine on different markers of cardiometabolic disease in women with stable angina.
Phase:
Phase 4
Details
Lead Sponsor:
University of Florida
Treatments:
Ranolazine